The University of Texas Health Science Center at San Antonio (UTHSCSA) has established the Institute for Integration of Medicine and Science (IIMS) as the home for our Clinical and Translational Science Award [CTSA). Our mission is to achieve optimal integration of clinical and translational research, education, training, and career development across all UTHSCSA schools and among our partner organizations in the South Texas region. IIMS will focus existing and newly developing resources and intellectual capital on advancing the discipline of clinical and translational research for the improvement of human health. Meaningful bidirectional community participation has promoted buy-in from all stakeholders and will remain a key principle as IIMS continues to evolve. IIMS partners have brought together major talent and a broad array of resources to create synergies that add value to all participating organizations, residents of our region and the CTSA network. Key function working groups have developed many innovative approaches to providing optimal support for IIMS investigators and programs. Distinctive features of IIMS include: 1) thriving partnerships with key public and private organizations (academic, health care, public health, military), 2) major investments in research resources and infrastructure, 3) the largest cadre of military health care and biomedical research operations in the US, 4) one of the world's largest primate research colonies, 5) a 46,000 square mile service area populated by predominantly Hispanic residents comprising some of the country's poorest people, plagued by high rates of health disparities, providing an opportunity, challenge and obligation for us to make a significant impact on human health. Within the context of our collective resources, community focus, and unique regional demographics, we have identified four Specific Aims as the core elements of our CTSA application:
Aim 1 - To support transformative clinical and translational research by providing a comprehensive infrastructure integrated effectively among our partners for the creation of multidisciplinary clinical research teams;
Aim 2 - To create the optimal intellectual environment and nurturing atmosphere necessary for the training of future clinical and translational career investigators, building upon existing strengths, partnerships, a diverse trainee pool and strong faculty dedication to mentoring;
Aim 3 - To develop community-based models that address the best means for translating research findings, focusing on our unique population-specific risk factors, disease burdens and health disparities;
Aim 4 - To implement robust tracking and outcome evaluation systems across all IIMS programs. The mission of IIMS is sharply focused on public health. Indeed, our primary vision is to work closely with all partners to translate the results of our academic and community-based research for the direct benefit of our regional population.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR000149-05S1
Application #
8667051
Study Section
Special Emphasis Panel (ZRR1-SRC (99))
Program Officer
Sawczuk, Andrea
Project Start
2008-05-19
Project End
2013-10-31
Budget Start
2013-06-07
Budget End
2013-10-31
Support Year
5
Fiscal Year
2013
Total Cost
$2,084,634
Indirect Cost
$538,952
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
de Jesús Garduno-Garcia, José; Gastaldelli, Amalia; DeFronzo, Ralph A et al. (2018) Older Subjects With ?-Cell Dysfunction Have an Accentuated Incretin Release. J Clin Endocrinol Metab 103:2613-2619
Rahman, Md Mizanur; El Jamali, Amina; Halade, Ganesh V et al. (2018) Nox2 Activity Is Required in Obesity-Mediated Alteration of Bone Remodeling. Oxid Med Cell Longev 2018:6054361
Foster, Byron A; Escaname, Elia; Powell, Theresa L et al. (2017) Randomized Controlled Trial of DHA Supplementation during Pregnancy: Child Adiposity Outcomes. Nutrients 9:
Lager, Susanne; Ramirez, Vanessa I; Acosta, Ometeotl et al. (2017) Docosahexaenoic Acid Supplementation in Pregnancy Modulates Placental Cellular Signaling and Nutrient Transport Capacity in Obese Women. J Clin Endocrinol Metab 102:4557-4567
Kawaguchi-Suzuki, M; Bril, F; Kalavalapalli, S et al. (2017) Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis. Aliment Pharmacol Ther 46:56-61
LoCoco, Peter M; Risinger, April L; Smith, Hudson R et al. (2017) Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy. Elife 6:
NGS in PPGL (NGSnPPGL) Study Group; Toledo, Rodrigo A; Burnichon, Nelly et al. (2017) Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 13:233-247
Li, Wei; Watts, Lora; Long, Justin et al. (2016) Spatiotemporal changes in blood-brain barrier permeability, cerebral blood flow, T2 and diffusion following mild traumatic brain injury. Brain Res 1646:53-61
Green, Dustin; Ruparel, Shivani; Gao, Xiaoli et al. (2016) Central activation of TRPV1 and TRPA1 by novel endogenous agonists contributes to mechanical allodynia and thermal hyperalgesia after burn injury. Mol Pain 12:
Shen, Qiang; Watts, Lora Tally; Li, Wei et al. (2016) Magnetic Resonance Imaging in Experimental Traumatic Brain Injury. Methods Mol Biol 1462:645-58

Showing the most recent 10 out of 209 publications